Nutrition
Volume 26, Issue 5 , Pages 556-562 , May 2010

Hypolipidemic effect of the polysaccharide from Pholiota nameko

Received 26 May 2009 ,Accepted 1 June 2009.

References 

  1. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease: the Framingham study. Ann Epidemiol. 1992;2:23–28
  2. Bobek P, Ozdin L, Kuniak L. Mechanism of hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats: reduction of cholesterol absorption and increase of plasma cholesterol removal. Z Ernahrungswiss. 1994;331:44–50
  3. Khanna PK, Bhandari R, Soni GL, Singh CK, Garcha HS, Mittar D. Role of mushroom (Pleurotus florida) as hypocholesterolemic/hypolipidemic agent. Indian J Exp Biol. 1993;31:567–568
  4. Sugiyama K, Kawagishi H, Tanaka A, Saeki S, Yoshida S, Sakamoto H, et al. Isolation of plasma cholesterol-lowering components from ningyotake (Polyporus confluens) mushroom. J Nutr Sci Vitaminol (Tokyo). 1992;38:335–342
  5. Bobek P, Ozdín L, Kuniak L, Hromadová M. Regulation of cholesterol metabolism with dietary addition of oyster mushrooms (Pleurotus ostreatus) in rats with hypercholesterolemia. Cas Lek Cesk. 1997;136:186–190
  6. Rajewska J, Bałasińska B. Biologically active compounds of edible mushrooms and their beneficial impact on health. Postepy Hig Med Dosw. 2004;58:352–357
  7. Li H, Lu X, Zhang S, Lu M, Liu H. Anti-inflammatory activity of polysaccharide from Pholiota nameko. Biochemistry (Mosc). 2008;73:669–675
  8. Li H, Wang S. Kinetics of inhibition of ribonuclease A by Pholiota nameko polysaccharide. Int J Biol Macromol. 2007;40:134–138
  9. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497–509
  10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J. Biol Chem. 1951;193:265–275
  11. Chang R. Functional properties of edible mushrooms. Nutr Rev. 1996;54:S91–S93
  12. Skoczyńska A. The role of lipids in atherogenesis. Postepy Hig Med Dosw. 2005;59:346–357
  13. Nancy LK, Judith AM, Clyde HA, Linda DH. Comparison of rat hepatic cholesterol biosynthesis during skim milk versus whey permeate ingestion. J Dairy Sci. 1982;65:2274–2280
  14. Kunitomo M. Oxidative stress and atherosclerosis [in Japanese]. Yakugaku Zasshi. 2007;127:1997–2014
  15. Catapano AL, Maggi FM, Tragni E. Low density lipoprotein oxidation, antioxidants, and atherosclerosis. Curr Opin Cardiol. 2000;15:355–363
  16. Percario S, Odorizzi VF, Souza DR, Pinhel MA, Gennari JL, Gennari MS, et al. Edible mushroom Agaricus sylvaticus can prevent the onset of atheroma plaques in hypercholesterolemic rabbits. Cell Mol Biol (Noisy-le-grand). 2008;54:OL1055–OL1061
  17. Newairy AA, Abdou HM. Protective role of flax lignans against lead acetate induced oxidative damage and hyperlipidemia in rats. Food Chem Toxicol. 2009;47:813–818
  18. Illingworth DR. The potential role of antioxidants in the prevention of atherosclerosis. J Nutr Sci Vitaminol (Tokyo). 1993;39:S43–S47
  19. Bernardo LW. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev Wajchenberg. 2000;21:697–738
  20. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144:2195–2200
  21. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89:2563–2568

PII: S0899-9007(09)00248-2

doi: 10.1016/j.nut.2009.06.009

Nutrition
Volume 26, Issue 5 , Pages 556-562 , May 2010

Article Tools

* Image Usage & Resolution